Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Cardioprotective Heme Oxygenase-1-PGC1α Signaling in Epicardial Fat Attenuates Cardiovascular Risk in Humans as in Obese Mice.

Singh SP, McClung JA, Thompson E, Glick Y, Greenberg M, Acosta-Baez G, Edris B, Shapiro JI, Abraham NG.

Obesity (Silver Spring). 2019 Oct;27(10):1634-1643. doi: 10.1002/oby.22608. Epub 2019 Aug 23.

2.

Acute myocardial infarction in the setting of left bundle branch block: Chapman's sign.

Idris A, Hatahet M, Edris B.

Am J Emerg Med. 2019 Jul 29:158378. doi: 10.1016/j.ajem.2019.158378. [Epub ahead of print]

PMID:
31395406
3.

Arterial embolism in a patient with pulmonary embolism and patent foramen ovale.

Abusnina W, Megri M, Edris B, El-Hamdani M.

Proc (Bayl Univ Med Cent). 2019 Mar 28;32(2):256-258. doi: 10.1080/08998280.2019.1576460. eCollection 2019 Apr.

4.

Smoking behaviour and patterns among university students during the Syrian crisis.

Idris A, Al Saadi T, Turk T, Alkhatib M, Zakaria M, Sawaf B, Edris B.

East Mediterr Health J. 2018 May 3;24(2):154-160.

5.

Self-reported study habits for enhancing medical students' performance in the National Medical Unified Examination.

Idris A, Al Saadi T, Edris B, Sawaf B, Zakaria MI, Alkhatib M, Turk T.

Avicenna J Med. 2016 Apr-Jun;6(2):39-46. doi: 10.4103/2231-0770.179553.

6.

A role for versican in the development of leiomyosarcoma.

Keire PA, Bressler SL, Lemire JM, Edris B, Rubin BP, Rahmani M, McManus BM, van de Rijn M, Wight TN.

J Biol Chem. 2014 Dec 5;289(49):34089-103. doi: 10.1074/jbc.M114.607168. Epub 2014 Oct 15.

7.

Use of a KIT-specific monoclonal antibody to bypass imatinib resistance in gastrointestinal stromal tumors.

Edris B, Willingham S, Weiskopf K, Volkmer AK, Volkmer JP, Mühlenberg T, Weissman IL, van de Rijn M.

Oncoimmunology. 2013 Jun 1;2(6):e24452. Epub 2013 May 14.

8.

Inactivation of the RB family prevents thymus involution and promotes thymic function by direct control of Foxn1 expression.

Garfin PM, Min D, Bryson JL, Serwold T, Edris B, Blackburn CC, Richie ER, Weinberg KI, Manley NR, Sage J, Viatour P.

J Exp Med. 2013 Jun 3;210(6):1087-97. doi: 10.1084/jem.20121716. Epub 2013 May 13.

9.

Anti-KIT monoclonal antibody inhibits imatinib-resistant gastrointestinal stromal tumor growth.

Edris B, Willingham SB, Weiskopf K, Volkmer AK, Volkmer JP, Mühlenberg T, Montgomery KD, Contreras-Trujillo H, Czechowicz A, Fletcher JA, West RB, Weissman IL, van de Rijn M.

Proc Natl Acad Sci U S A. 2013 Feb 26;110(9):3501-6. doi: 10.1073/pnas.1222893110. Epub 2013 Feb 4.

10.

Flipping the script on macrophages in leiomyosarcoma.

Edris B, Weiskopf K, Weissman IL, van de Rijn M.

Oncoimmunology. 2012 Oct 1;1(7):1202-1204.

11.

Transcriptional profiling of long non-coding RNAs and novel transcribed regions across a diverse panel of archived human cancers.

Brunner AL, Beck AH, Edris B, Sweeney RT, Zhu SX, Li R, Montgomery K, Varma S, Gilks T, Guo X, Foley JW, Witten DM, Giacomini CP, Flynn RA, Pollack JR, Tibshirani R, Chang HY, van de Rijn M, West RB.

Genome Biol. 2012 Aug 28;13(8):R75. doi: 10.1186/gb-2012-13-8-r75.

12.

Comparative gene expression profiling of benign and malignant lesions reveals candidate therapeutic compounds for leiomyosarcoma.

Edris B, Fletcher JA, West RB, van de Rijn M, Beck AH.

Sarcoma. 2012;2012:805614. doi: 10.1155/2012/805614. Epub 2012 Aug 5.

13.

Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcoma.

Edris B, Weiskopf K, Volkmer AK, Volkmer JP, Willingham SB, Contreras-Trujillo H, Liu J, Majeti R, West RB, Fletcher JA, Beck AH, Weissman IL, van de Rijn M.

Proc Natl Acad Sci U S A. 2012 Apr 24;109(17):6656-61. doi: 10.1073/pnas.1121629109. Epub 2012 Mar 26.

14.

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors.

Willingham SB, Volkmer JP, Gentles AJ, Sahoo D, Dalerba P, Mitra SS, Wang J, Contreras-Trujillo H, Martin R, Cohen JD, Lovelace P, Scheeren FA, Chao MP, Weiskopf K, Tang C, Volkmer AK, Naik TJ, Storm TA, Mosley AR, Edris B, Schmid SM, Sun CK, Chua MS, Murillo O, Rajendran P, Cha AC, Chin RK, Kim D, Adorno M, Raveh T, Tseng D, Jaiswal S, Enger PØ, Steinberg GK, Li G, So SK, Majeti R, Harsh GR, van de Rijn M, Teng NN, Sunwoo JB, Alizadeh AA, Clarke MF, Weissman IL.

Proc Natl Acad Sci U S A. 2012 Apr 24;109(17):6662-7. doi: 10.1073/pnas.1121623109. Epub 2012 Mar 26.

15.

ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumour.

Edris B, Espinosa I, Mühlenberg T, Mikels A, Lee CH, Steigen SE, Zhu S, Montgomery KD, Lazar AJ, Lev D, Fletcher JA, Beck AH, West RB, Nusse R, van de Rijn M.

J Pathol. 2012 Jun;227(2):223-33. doi: 10.1002/path.3986. Epub 2012 Feb 17.

16.

CSF1 expression in nongynecological leiomyosarcoma is associated with increased tumor angiogenesis.

Espinosa I, Edris B, Lee CH, Cheng HW, Gilks CB, Wang Y, Montgomery KD, Varma S, Li R, Marinelli RJ, West RB, Nielsen T, Beck AH, van de Rijn M.

Am J Pathol. 2011 Oct;179(4):2100-7. doi: 10.1016/j.ajpath.2011.06.021. Epub 2011 Aug 18.

17.

Discovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling.

Beck AH, Lee CH, Witten DM, Gleason BC, Edris B, Espinosa I, Zhu S, Li R, Montgomery KD, Marinelli RJ, Tibshirani R, Hastie T, Jablons DM, Rubin BP, Fletcher CD, West RB, van de Rijn M.

Oncogene. 2010 Feb 11;29(6):845-54. doi: 10.1038/onc.2009.381. Epub 2009 Nov 9.

18.

Prevalence of peripheral artery disease varies significantly depending upon the method of calculating ankle brachial index.

Reed JF 3rd, Eid S, Edris B, Sumner AD.

Eur J Cardiovasc Prev Rehabil. 2009 Jun;16(3):377-81. doi: 10.1097/HJR.0b013e32832955e2.

PMID:
19369879
19.

The macrophage colony-stimulating factor 1 response signature in breast carcinoma.

Beck AH, Espinosa I, Edris B, Li R, Montgomery K, Zhu S, Varma S, Marinelli RJ, van de Rijn M, West RB.

Clin Cancer Res. 2009 Feb 1;15(3):778-87. doi: 10.1158/1078-0432.CCR-08-1283.

20.

MRSA infection in lower extremity wounds.

Edris B, Reed JF 3rd.

Int J Low Extrem Wounds. 2008 Mar;7(1):28-31. doi: 10.1177/1534734608314090.

PMID:
18372266

Supplemental Content

Support Center